consort healthcare (birmingham) limited Company Information
Company Number
05537895
Next Accounts
Sep 2025
Shareholders
consort healthcare (birmingham) holdings limited
Group Structure
View All
Industry
Hospital activities
Registered Address
unit 18 riversway business villa, navigation way, preston, PR2 2YP
Website
caretech-uk.comconsort healthcare (birmingham) limited Estimated Valuation
Pomanda estimates the enterprise value of CONSORT HEALTHCARE (BIRMINGHAM) LIMITED at £53.3m based on a Turnover of £49.9m and 1.07x industry multiple (adjusted for size and gross margin).
consort healthcare (birmingham) limited Estimated Valuation
Pomanda estimates the enterprise value of CONSORT HEALTHCARE (BIRMINGHAM) LIMITED at £22.7m based on an EBITDA of £3.1m and a 7.4x industry multiple (adjusted for size and gross margin).
consort healthcare (birmingham) limited Estimated Valuation
Pomanda estimates the enterprise value of CONSORT HEALTHCARE (BIRMINGHAM) LIMITED at £0 based on Net Assets of £-10.3m and 2.53x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Consort Healthcare (birmingham) Limited Overview
Consort Healthcare (birmingham) Limited is a live company located in preston, PR2 2YP with a Companies House number of 05537895. It operates in the hospital activities sector, SIC Code 86101. Founded in August 2005, it's largest shareholder is consort healthcare (birmingham) holdings limited with a 100% stake. Consort Healthcare (birmingham) Limited is a mature, large sized company, Pomanda has estimated its turnover at £49.9m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Consort Healthcare (birmingham) Limited Health Check
Pomanda's financial health check has awarded Consort Healthcare (Birmingham) Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs


5 Strong

1 Regular

4 Weak

Size
annual sales of £49.9m, make it larger than the average company (£4.2m)
£49.9m - Consort Healthcare (birmingham) Limited
£4.2m - Industry AVG

Growth
3 year (CAGR) sales growth of 12%, show it is growing at a faster rate (8.5%)
12% - Consort Healthcare (birmingham) Limited
8.5% - Industry AVG

Production
with a gross margin of 27.4%, this company has a higher cost of product (36.1%)
27.4% - Consort Healthcare (birmingham) Limited
36.1% - Industry AVG

Profitability
an operating margin of 6.2% make it less profitable than the average company (11.6%)
6.2% - Consort Healthcare (birmingham) Limited
11.6% - Industry AVG

Employees
with 625 employees, this is above the industry average (48)
- Consort Healthcare (birmingham) Limited
48 - Industry AVG

Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Consort Healthcare (birmingham) Limited
- - Industry AVG

Efficiency
resulting in sales per employee of £79.8k, this is equally as efficient (£79.8k)
- Consort Healthcare (birmingham) Limited
£79.8k - Industry AVG

Debtor Days
it gets paid by customers after 12 days, this is earlier than average (28 days)
12 days - Consort Healthcare (birmingham) Limited
28 days - Industry AVG

Creditor Days
its suppliers are paid after 17 days, this is quicker than average (30 days)
17 days - Consort Healthcare (birmingham) Limited
30 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Consort Healthcare (birmingham) Limited
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 45 weeks, this is more cash available to meet short term requirements (29 weeks)
45 weeks - Consort Healthcare (birmingham) Limited
29 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 101.2%, this is a higher level of debt than the average (49.3%)
101.2% - Consort Healthcare (birmingham) Limited
49.3% - Industry AVG
CONSORT HEALTHCARE (BIRMINGHAM) LIMITED financials

Consort Healthcare (Birmingham) Limited's latest turnover from December 2023 is £49.9 million and the company has net assets of -£10.3 million. According to their latest financial statements, we estimate that Consort Healthcare (Birmingham) Limited has 625 employees and maintains cash reserves of £162.8 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 49,853,000 | 40,058,000 | 39,218,000 | 35,396,000 | 34,469,000 | 34,116,000 | 31,632,000 | 29,598,000 | 33,646,000 | 29,274,000 | 28,076,000 | 35,000,000 | 162,186,000 | 510,770,000 | 33,407,000 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 36,198,000 | 29,419,000 | 28,294,000 | 26,490,000 | 26,018,000 | 26,187,000 | 23,673,000 | 21,837,000 | 26,311,000 | 22,097,000 | 21,315,000 | 26,612,000 | 154,729,000 | 506,883,000 | 31,735,000 |
Gross Profit | 13,655,000 | 10,639,000 | 10,924,000 | 8,906,000 | 8,451,000 | 7,929,000 | 7,959,000 | 7,761,000 | 7,335,000 | 7,177,000 | 6,761,000 | 8,388,000 | 7,457,000 | 3,887,000 | 1,672,000 |
Admin Expenses | 10,590,000 | 5,539,000 | 7,114,000 | 4,083,000 | 3,475,000 | 2,829,000 | 3,463,000 | 3,193,000 | 2,843,000 | 2,645,000 | 2,371,000 | 2,932,000 | 3,394,000 | 1,918,000 | 293,000 |
Operating Profit | 3,065,000 | 5,100,000 | 3,810,000 | 4,823,000 | 4,976,000 | 5,100,000 | 4,496,000 | 4,568,000 | 4,492,000 | 4,532,000 | 4,390,000 | 5,456,000 | 4,063,000 | 1,969,000 | 1,379,000 |
Interest Payable | 78,283,000 | 60,788,000 | 46,897,000 | 46,567,000 | 44,769,000 | 43,087,000 | 41,074,000 | 40,493,000 | 43,428,000 | 44,721,000 | 45,346,000 | 45,198,000 | 44,914,000 | 43,068,000 | 35,676,000 |
Interest Receivable | 52,669,000 | 42,607,000 | 38,331,000 | 38,993,000 | 39,262,000 | 39,481,000 | 39,507,000 | 41,628,000 | 44,411,000 | 45,502,000 | 45,531,000 | 43,728,000 | 43,301,000 | 43,414,000 | 36,674,000 |
Pre-Tax Profit | -22,549,000 | -13,081,000 | -4,756,000 | -2,751,000 | -531,000 | 1,494,000 | 2,929,000 | 5,703,000 | 5,475,000 | 5,313,000 | 4,575,000 | 3,986,000 | 2,450,000 | 2,315,000 | 2,377,000 |
Tax | 5,299,000 | -589,000 | -349,000 | -537,000 | -855,000 | -284,000 | -564,000 | -1,141,000 | -1,109,000 | -1,131,000 | -1,051,000 | -1,041,000 | -650,000 | -648,000 | -685,000 |
Profit After Tax | -17,250,000 | -13,670,000 | -5,105,000 | -3,288,000 | -1,386,000 | 1,210,000 | 2,365,000 | 4,562,000 | 4,366,000 | 4,182,000 | 3,524,000 | 2,945,000 | 1,800,000 | 1,667,000 | 1,692,000 |
Dividends Paid | |||||||||||||||
Retained Profit | -17,250,000 | -13,670,000 | -5,105,000 | -3,288,000 | -1,386,000 | 1,210,000 | 2,365,000 | 4,562,000 | 4,366,000 | 4,182,000 | 3,524,000 | 2,945,000 | 1,800,000 | 1,667,000 | 1,692,000 |
Employee Costs | |||||||||||||||
Number Of Employees | |||||||||||||||
EBITDA* | 3,065,000 | 5,100,000 | 3,810,000 | 4,823,000 | 4,976,000 | 5,100,000 | 4,496,000 | 4,568,000 | 4,492,000 | 4,532,000 | 4,390,000 | 5,456,000 | 4,063,000 | 1,969,000 | 1,379,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 2,000 | 8,000 | 8,000 | 6,000 | 6,000 | 6,000 | 6,000 | ||||||||
Intangible Assets | |||||||||||||||
Investments & Other | 22,088,000 | ||||||||||||||
Debtors (Due After 1 year) | 670,919,000 | 676,190,000 | 679,356,000 | 679,597,000 | 686,794,000 | 695,927,000 | 702,951,000 | 705,225,000 | 712,036,000 | 710,870,000 | 708,675,000 | 705,985,000 | 697,338,000 | 557,279,000 | 66,716,000 |
Total Fixed Assets | 670,919,000 | 676,190,000 | 679,356,000 | 679,597,000 | 686,794,000 | 695,927,000 | 702,951,000 | 705,227,000 | 712,044,000 | 710,878,000 | 708,675,000 | 705,991,000 | 697,344,000 | 557,285,000 | 88,810,000 |
Stock & work in progress | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 121,635,000 | 576,062,000 | ||||||||
Trade Debtors | 1,665,000 | 1,197,000 | 5,531,000 | 1,732,000 | 1,222,000 | 4,583,000 | 1,050,000 | 1,289,000 | 589,000 | 1,734,000 | 2,947,000 | 4,423,000 | 5,917,000 | 9,232,000 | 2,819,000 |
Group Debtors | |||||||||||||||
Misc Debtors | 5,069,000 | 3,717,000 | 2,528,000 | 3,955,000 | 4,342,000 | 633,000 | 2,843,000 | 5,243,000 | 858,000 | 1,118,000 | 974,000 | 1,836,000 | 4,918,000 | 1,503,000 | 2,804,000 |
Cash | 162,800,000 | 150,778,000 | 135,392,000 | 123,558,000 | 113,110,000 | 92,859,000 | 75,872,000 | 66,630,000 | 18,810,000 | 18,919,000 | 17,243,000 | 48,457,000 | 33,333,000 | 17,413,000 | 10,241,000 |
misc current assets | 5,963,000 | 940,000 | 40,011,000 | 37,114,000 | 33,730,000 | 22,088,000 | 7,423,000 | ||||||||
total current assets | 175,497,000 | 156,632,000 | 143,451,000 | 129,245,000 | 118,674,000 | 98,075,000 | 79,765,000 | 73,162,000 | 60,274,000 | 58,891,000 | 54,900,000 | 54,722,000 | 44,174,000 | 171,871,000 | 599,349,000 |
total assets | 846,416,000 | 832,822,000 | 822,807,000 | 808,842,000 | 805,468,000 | 794,002,000 | 782,716,000 | 778,389,000 | 772,318,000 | 769,769,000 | 763,575,000 | 760,713,000 | 741,518,000 | 729,156,000 | 688,159,000 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 1,732,000 | 2,000,000 | 1,594,000 | 1,411,000 | 946,000 | 1,295,000 | 1,689,000 | 1,114,000 | 1,034,000 | 441,000 | 478,000 | 1,819,000 | 1,574,000 | 938,000 | 271,000 |
Group/Directors Accounts | 6,501,000 | 1,629,000 | |||||||||||||
other short term finances | 178,396,000 | 137,578,000 | 109,031,000 | 92,773,000 | 76,925,000 | 61,322,000 | 53,261,000 | 40,482,000 | 37,896,000 | 38,338,000 | 36,148,000 | 37,945,000 | 24,990,000 | 16,998,000 | 3,007,000 |
hp & lease commitments | |||||||||||||||
other current liabilities | 6,171,000 | 9,454,000 | 7,256,000 | 5,495,000 | 8,986,000 | 6,339,000 | 3,800,000 | 8,590,000 | 7,289,000 | 9,327,000 | 9,977,000 | 8,541,000 | 6,566,000 | 4,497,000 | 2,855,000 |
total current liabilities | 186,299,000 | 149,032,000 | 117,881,000 | 99,679,000 | 86,857,000 | 68,956,000 | 58,750,000 | 50,186,000 | 46,219,000 | 48,106,000 | 46,603,000 | 48,305,000 | 33,130,000 | 28,934,000 | 7,762,000 |
loans | 662,411,000 | 668,834,000 | 676,300,000 | 683,432,000 | 689,592,000 | 694,641,000 | 694,771,000 | 701,373,000 | 703,831,000 | 703,761,000 | 703,252,000 | 702,212,000 | 701,137,000 | 694,771,000 | 676,613,000 |
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | 8,000,000 | 8,000,000 | 8,000,000 | ||||||||||||
provisions | |||||||||||||||
total long term liabilities | 670,411,000 | 676,834,000 | 684,300,000 | 683,432,000 | 689,592,000 | 694,641,000 | 694,771,000 | 701,373,000 | 703,831,000 | 703,761,000 | 703,252,000 | 702,212,000 | 701,137,000 | 694,771,000 | 676,613,000 |
total liabilities | 856,710,000 | 825,866,000 | 802,181,000 | 783,111,000 | 776,449,000 | 763,597,000 | 753,521,000 | 751,559,000 | 750,050,000 | 751,867,000 | 749,855,000 | 750,517,000 | 734,267,000 | 723,705,000 | 684,375,000 |
net assets | -10,294,000 | 6,956,000 | 20,626,000 | 25,731,000 | 29,019,000 | 30,405,000 | 29,195,000 | 26,830,000 | 22,268,000 | 17,902,000 | 13,720,000 | 10,196,000 | 7,251,000 | 5,451,000 | 3,784,000 |
total shareholders funds | -10,294,000 | 6,956,000 | 20,626,000 | 25,731,000 | 29,019,000 | 30,405,000 | 29,195,000 | 26,830,000 | 22,268,000 | 17,902,000 | 13,720,000 | 10,196,000 | 7,251,000 | 5,451,000 | 3,784,000 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 3,065,000 | 5,100,000 | 3,810,000 | 4,823,000 | 4,976,000 | 5,100,000 | 4,496,000 | 4,568,000 | 4,492,000 | 4,532,000 | 4,390,000 | 5,456,000 | 4,063,000 | 1,969,000 | 1,379,000 |
Depreciation | |||||||||||||||
Amortisation | |||||||||||||||
Tax | 5,299,000 | -589,000 | -349,000 | -537,000 | -855,000 | -284,000 | -564,000 | -1,141,000 | -1,109,000 | -1,131,000 | -1,051,000 | -1,041,000 | -650,000 | -648,000 | -685,000 |
Stock | -6,000 | -121,629,000 | -454,427,000 | 576,062,000 | |||||||||||
Debtors | -3,451,000 | -6,311,000 | 2,131,000 | -7,074,000 | -8,785,000 | -5,701,000 | -4,913,000 | -1,726,000 | -239,000 | 1,126,000 | 352,000 | 4,071,000 | 140,159,000 | 495,675,000 | 72,339,000 |
Creditors | -268,000 | 406,000 | 183,000 | 465,000 | -349,000 | -394,000 | 575,000 | 80,000 | 593,000 | -37,000 | -1,341,000 | 245,000 | 636,000 | 667,000 | 271,000 |
Accruals and Deferred Income | -3,283,000 | 2,198,000 | 1,761,000 | -3,491,000 | 2,647,000 | 2,539,000 | -4,790,000 | 1,301,000 | -2,038,000 | -650,000 | 1,436,000 | 1,975,000 | 2,069,000 | 1,642,000 | 2,855,000 |
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | 8,264,000 | 13,426,000 | 3,274,000 | 8,334,000 | 15,204,000 | 12,662,000 | 4,630,000 | 6,540,000 | 2,177,000 | 1,588,000 | 3,082,000 | 2,564,000 | -12,412,000 | -37,618,000 | -644,581,000 |
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | -22,088,000 | 22,088,000 | |||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | -6,501,000 | 4,872,000 | 1,629,000 | ||||||||||||
Other Short Term Loans | 40,818,000 | 28,547,000 | 16,258,000 | 15,848,000 | 15,603,000 | 8,061,000 | 12,779,000 | 2,586,000 | -442,000 | 2,190,000 | -1,797,000 | 12,955,000 | 7,992,000 | 13,991,000 | 3,007,000 |
Long term loans | -6,423,000 | -7,466,000 | -7,132,000 | -6,160,000 | -5,049,000 | -130,000 | -6,602,000 | -2,458,000 | 70,000 | 509,000 | 1,040,000 | 1,075,000 | 6,366,000 | 18,158,000 | 676,613,000 |
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | 8,000,000 | ||||||||||||||
share issue | |||||||||||||||
interest | -25,614,000 | -18,181,000 | -8,566,000 | -7,574,000 | -5,507,000 | -3,606,000 | -1,567,000 | 1,135,000 | 983,000 | 781,000 | 185,000 | -1,470,000 | -1,613,000 | 346,000 | 998,000 |
cash flow from financing | 8,781,000 | 2,900,000 | 8,560,000 | 2,114,000 | 5,047,000 | 4,325,000 | 4,610,000 | 1,263,000 | 611,000 | 3,480,000 | -572,000 | 12,560,000 | 6,244,000 | 37,367,000 | 684,339,000 |
cash and cash equivalents | |||||||||||||||
cash | 12,022,000 | 15,386,000 | 11,834,000 | 10,448,000 | 20,251,000 | 16,987,000 | 9,242,000 | 47,820,000 | -109,000 | 1,676,000 | -31,214,000 | 15,124,000 | 15,920,000 | 7,172,000 | 10,241,000 |
overdraft | |||||||||||||||
change in cash | 12,022,000 | 15,386,000 | 11,834,000 | 10,448,000 | 20,251,000 | 16,987,000 | 9,242,000 | 47,820,000 | -109,000 | 1,676,000 | -31,214,000 | 15,124,000 | 15,920,000 | 7,172,000 | 10,241,000 |
consort healthcare (birmingham) limited Credit Report and Business Information
Consort Healthcare (birmingham) Limited Competitor Analysis

Perform a competitor analysis for consort healthcare (birmingham) limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in PR2 area or any other competitors across 12 key performance metrics.
consort healthcare (birmingham) limited Ownership
CONSORT HEALTHCARE (BIRMINGHAM) LIMITED group structure
Consort Healthcare (Birmingham) Limited has no subsidiary companies.
Ultimate parent company
1 parent
CONSORT HEALTHCARE (BIRMINGHAM) LIMITED
05537895
consort healthcare (birmingham) limited directors
Consort Healthcare (Birmingham) Limited currently has 6 directors. The longest serving directors include Mr Stephen Worthy (Aug 2019) and Mr Stephen Worthy (Aug 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Stephen Worthy | United Kingdom | 48 years | Aug 2019 | - | Director |
Mr Stephen Worthy | England | 48 years | Aug 2019 | - | Director |
Mr Brian Walker | 69 years | Sep 2021 | - | Director | |
Mr William Morris | United Kingdom | 45 years | Nov 2021 | - | Director |
Mr William Morris | United Kingdom | 45 years | Nov 2021 | - | Director |
Mr Andrew Deacon | United Kingdom | 45 years | Nov 2021 | - | Director |
P&L
December 2023turnover
49.9m
+24%
operating profit
3.1m
-40%
gross margin
27.4%
+3.13%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-10.3m
-2.48%
total assets
846.4m
+0.02%
cash
162.8m
+0.08%
net assets
Total assets minus all liabilities
consort healthcare (birmingham) limited company details
company number
05537895
Type
Private limited with Share Capital
industry
86101 - Hospital activities
incorporation date
August 2005
age
20
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
KPMG LLP
address
unit 18 riversway business villa, navigation way, preston, PR2 2YP
Bank
-
Legal Advisor
-
consort healthcare (birmingham) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to consort healthcare (birmingham) limited. Currently there are 4 open charges and 0 have been satisfied in the past.
consort healthcare (birmingham) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CONSORT HEALTHCARE (BIRMINGHAM) LIMITED. This can take several minutes, an email will notify you when this has completed.
consort healthcare (birmingham) limited Companies House Filings - See Documents
date | description | view/download |
---|